Literature DB >> 16301828

Establishment and characterization of a novel polarized MDCK epithelial cellular model for CFTR studies.

Filipa Mendes1, John Wakefield, Tanja Bachhuber, Margarida Barroso, Zsuzsa Bebok, Deborah Penque, Karl Kunzelmann, Margarida D Amaral.   

Abstract

F508del is the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsible for the genetic disease Cystic Fibrosis (CF). It results in a major failure of CFTR to traffic to the apical membrane of epithelial cells, where it should function as a chloride (Cl-) channel. Most studies on localization, processing and cellular trafficking of wild-type (wt) and F508del-CFTR have been performed in non-epithelial cells. Notwithstanding, polarized epithelial cells possess distinctly organized and regulated membrane trafficking pathways. We have used Madin-Darby canine kidney (MDCK) type II cells (proximal tubular cells which do not express endogenous CFTR) to generate novel epithelial, polarized cellular models stably expressing wt- or F508del-CFTR through transduction with recombinant lentiviral vectors. Characterization of these cell lines shows that wt-CFTR is correctly processed and apically localized, producing a cAMP-activated Cl- conductance. In contrast, F508del-CFTR is mostly detected in itsimmature form, localized intracellularly and producing only residual Cl- conductance. These novel cell lines constitute bona fide models and significantly improved resources to investigate the molecular mechanisms of polarized membrane traffic of wt- and F508del-CFTR in the same cellular background. They are also useful to identify/validate novel therapeutic compounds for CF. (c) 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301828     DOI: 10.1159/000089857

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

Review 1.  Therapy through chaperones: sense or antisense? Cystic fibrosis as a model disease.

Authors:  Margarida D Amaral
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

2.  Folding and rescue of a cystic fibrosis transmembrane conductance regulator trafficking mutant identified using human-murine chimeric proteins.

Authors:  Ana Carina Da Paula; Marisa Sousa; Zhe Xu; Elizabeth S Dawson; A Christopher Boyd; David N Sheppard; Margarida D Amaral
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

3.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

4.  Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa.

Authors:  Alice E Davidson; Ian D Millar; Jill E Urquhart; Rosemary Burgess-Mullan; Yusrah Shweikh; Neil Parry; James O'Sullivan; Geoffrey J Maher; Martin McKibbin; Susan M Downes; Andrew J Lotery; Samuel G Jacobson; Peter D Brown; Graeme C M Black; Forbes D C Manson
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

5.  Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator.

Authors:  A Schmidt; L K Hughes; Z Cai; F Mendes; H Li; D N Sheppard; M D Amaral
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

6.  Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.

Authors:  Neeraj Sharma; Taylor A Evans; Matthew J Pellicore; Emily Davis; Melis A Aksit; Allison F McCague; Anya T Joynt; Zhongzhu Lu; Sangwoo T Han; Arianna F Anzmann; Anh-Thu N Lam; Abigail Thaxton; Natalie West; Christian Merlo; Laura B Gottschalk; Karen S Raraigh; Patrick R Sosnay; Calvin U Cotton; Garry R Cutting
Journal:  PLoS Genet       Date:  2018-11-16       Impact factor: 5.917

7.  TMEM16A drives renal cyst growth by augmenting Ca2+ signaling in M1 cells.

Authors:  Ines Cabrita; Björn Buchholz; Rainer Schreiber; Karl Kunzelmann
Journal:  J Mol Med (Berl)       Date:  2020-03-18       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.